Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas

[1]  Stefano Monti,et al.  SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. , 2008, Blood.

[2]  P. Greipp,et al.  Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders , 2007, Leukemia.

[3]  Feifei Zhao,et al.  Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. , 2007, Clinical immunology.

[4]  G. Laurent,et al.  Syk-dependent mTOR activation in follicular lymphoma cells. , 2006, Blood.

[5]  G. Dewald,et al.  The Incidence and Anatomic Site Specificity of Chromosomal Translocations in Primary Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in North America , 2006, The American journal of surgical pathology.

[6]  Jonathan M Irish,et al.  Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. , 2006, Blood.

[7]  D. Aronoff,et al.  Differential regulation by leukotrienes and calcium of Fcγ receptor‐induced phagocytosis and Syk activation in dendritic cells versus macrophages , 2006, Journal of leukocyte biology.

[8]  Francesco Bertoni,et al.  Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma , 2006, British journal of haematology.

[9]  R. Siebert,et al.  Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma , 2006, Leukemia.

[10]  T. Grogan,et al.  Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures , 2005, Molecular Cancer Therapeutics.

[11]  E. Campo,et al.  Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. , 2005, Blood.

[12]  Terry L. Smith,et al.  Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma , 2005, Cancer.

[13]  A. Rosenwald,et al.  Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. , 2005, Human pathology.

[14]  Y. Natkunam,et al.  Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma , 2005, Leukemia.

[15]  R. Gascoyne,et al.  Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Y. Natkunam,et al.  Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples , 2004, British journal of haematology.

[17]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[18]  P. Vyas,et al.  Pathology and genetics: Tumours of haematopoietic and lymphoid tissues , 2001 .

[19]  N. Harris,et al.  Peripheral T-Cell Lymphoma With Follicular Involvement and a CD4+/bcl-6+ Phenotype , 2001, The American journal of surgical pathology.

[20]  Randall L. Kincaid,et al.  Phosphorylation of Syk Activation Loop Tyrosines Is Essential for Syk Function , 2000, The Journal of Biological Chemistry.

[21]  T. Kurosaki,et al.  B Cell Antigen Receptor-Induced Activation of Akt Promotes B Cell Survival and Is Dependent on Syk Kinase1 , 2000, The Journal of Immunology.

[22]  J. D. Di Santo,et al.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling. , 2000, Immunology today.

[23]  A. Israël,et al.  Altered Expression of Tyrosine Kinases of the Src and Syk Families in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines , 1999, Journal of Virology.

[24]  P. Leibson,et al.  Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity , 1997, The Journal of experimental medicine.

[25]  A. Weiss,et al.  Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. , 1994, Journal of immunology.